The Kaplan-Meier survival analysis was used to describe the survival curves of the CFL1 and PGK1 over-expression groups and low-expression groups within each WHO grade II, WHO grade III and WHO grade IV gliomas. This evidence concerns the gene PGK1 and central nervous system cancer.